(Q34397588)
Statements
1 reference
Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis (English)
1 reference
K Kubota
Y Ichinose
G Scagliotti
D Spigel
J H Kim
T Shinkai
K Takeda
S-W Kim
T-C Hsia
R K Li
B J Tiangco
S Yau
B Yao
Y-J Hei
13 January 2014
1 reference